Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

Inclusion Criteria: • Patients with visual impairment secondary to branch retinal vein occlusion (BRVO) with a BCVA between 19 and 73 letters in one eye and at least 35 letters in the other eye. Exclusion Criteria: * Pregnant or nursing women or women of child bearing potential without unless using an effective contraception * Stroke or myocard infarction within 3 months prior to study * History of malignancy within the past 5 years * Uncontrolled hypertension * Active infection or inflammation in any eye * use of corticosteroids for at least 30 days in the last 6 months * treatment with anti-angiogenic drugs in any eye within last 3 months * Panretinal or focal/drid laser photocoagulation within the last few months